粘膜疫苗接种策略,以防困难菌感染
Joshua Heuler1, Harish Chandra2, Xingmin Sun1
1Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL 33612, USA.
Vaccines
|May 27, 2023
概括
开发针对Clostridioides difficile感染 (CDI) 的粘膜疫苗对于预防复发性腹和炎症至关重要. 本综述考察了针对毒素,细胞成分和子的疫苗策略,以对抗这种公共卫生威胁.
科学领域:
- 微生物学和免疫学
- 疫苗开发 疫苗开发
- 传染性疾病 传染性疾病
背景情况:
- 困难菌感染 (CDI) 是一个重要的公共卫生问题,导致经常性腹和肠道炎症.
- 病原体的抗生素耐药性和子形成使医疗保健机构的根除复杂化.
- 便-口腔传播突出了粘膜疫苗在预防方面的潜力.
研究的目的:
- 审查开发针对CDI的粘膜疫苗的进展情况.
- 评估各种抗原,包括毒素,细胞表面成分和子蛋白.
- 以指导未来的研究,以获得有效的CDI粘膜疫苗.
主要方法:
- 对CDI的粘膜疫苗的当前研究的文献综述.
- 对疫苗开发的不同抗原点的分析.
- 评估向粘膜部位输送抗原的方法.
主要成果:
- 目前正在研究几个有前途的抗原候选人用于粘膜疫苗.
- 不同的疫苗输送策略显示了诱导粘膜免疫的不同潜力.
- 在优化免疫性和疗效方面仍然存在挑战.
结论:
- 粘膜疫苗是预防CDI殖民和疾病的有希望的策略.
- 需要进一步的研究来优化抗原选择和有效的CDI疫苗的输送.
- 成功开发可以显著减少CDI在医疗保健机构的负担.
相关概念视频
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
581
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
581
Mucosal Barrier of the Stomach
730
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
730
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
519
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
519
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
474
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
474
Microorganisms in Medicine and Therapeutics
74
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
74
Vaccinations
44.9K
Overview
44.9K


